Epstein Barr Virus Infection clinical trials

Explore recruiting epstein barr virus infection clinical trials.

Recruiting epstein barr virus infection studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Epstein Barr Virus Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LEBV® and 2LXFS® on asthenia in patients with an EBV infection

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Dosing EvaLuation of Tenofovir Alafenamide on Epstein-Barr Virus (The DELTA-EBV study)

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Epstein Barr Virus Infection trials by city

Epstein Barr Virus Infection clinical trials

Recruiting epstein barr virus infection studies right now

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia

Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection

Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL

Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)

JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Also recruiting in Europe

Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LEBV® and 2LXFS® on asthenia in patients with an EBV infection

Dosing EvaLuation of Tenofovir Alafenamide on Epstein-Barr Virus (The DELTA-EBV study)

Epstein Barr Virus Infection trials by city

Other conditions